A clinical breakthrough, explained so people trust it.
Breath Diagnostics is a medical-technology company whose OneBreath platform screens for early-stage lung cancer from a single exhale, and holds an FDA Breakthrough Device Designation. I designed and built the website that makes that science clear and credible to clinicians, investors, and the press.
Turning rigorous science into a story people trust.
OneBreath is a genuinely complex diagnostic: microreactor chemistry, mass spectrometry, and a large clinical validation behind it. The site had to convey that rigor without burying a non-specialist reader.
The design leads with the human promise of early detection, then lets the clinical depth, the validation, and the team carry the credibility.
- Client
- Breath Diagnostics, Inc.
- Sector
- Medical technology
- Year
- 2026
- Role
- Website design & build
Hard science, high stakes, mixed audience.
A diagnostics company has to satisfy clinicians and investors who want rigor, and reassure patients who want hope, all on the same site. The challenge was presenting clinical-grade detail and a warm, human promise without either one undermining the other.
What I built, and how it came together.
A credible, human site for a clinical breakthrough.
A site that opens with the promise of early detection, then carries the technology, the clinical validation, the team, and the latest milestones.
A small number of moves, each one shipped.
Each stage shipped its own deliverables, so the work stayed visible and correctable before the next one started.
Frame the story
Lead with the human promise, support it with clinical rigor.
Explain the science
Translate microreactor chemistry and MS analysis for a mixed audience.
Build it
A responsive site with team, blog, and news systems.
Launch
Shipped to support clinical, investor, and press audiences.
A closer look at what shipped.
Rigor and hope on the same page.
The site gives Breath Diagnostics a credible home for a complex clinical story, legible to clinicians and investors while still reassuring to patients. The figures below are the company's own clinical results.
FDA
Breakthrough Device Designation
94% / 85%
sensitivity / specificity (OneBreath)
800+
patients in clinical validation
Start with a short call. Straight answer either way.
Tell me what you are trying to ship. We scope it, price it, and decide the right way in.
One letter, every Sunday. Working systems, not hot takes.
Build logs, working systems, and field notes from running a portfolio of AI ventures. Sent weekly, never more.